Griffith Harsh
Academic Appointments
- Professor - Med Center Line, Neurosurgery
- Member, Bio-X
- Member, Stanford Cancer Institute
- Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
Key Documents
Contact Information
-
Clinical Offices
Neurosurgery 875 Blake Wilbur Dr Clinic D Stanford, CA 94305 Tel Work (650) 736-7440 Fax (650) 498-4686Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 725-0701Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Neuro Oncology
- Acoustic Neuroma
- Acoustic Neuroma - Head and Neck Surgery
- Brain / Central Nervous System Tumors
- Brain / Central Nervous System Tumors - Neuro Oncology
- Brain / Central Nervous System Tumors - Neurosurgery
Administrative Appointments
- Director, Stanford Brain Tumor Center (2010 - present)
- Associate Dean, CME Education, Stanford University School of Medicine (2012 - present)
- Program Director, Stanford Neurosurgery Resident Training Program (2004 - 2006)
- Surgical Director, Stanford Pituitary Center (2004 - 2006)
- Director, Stanford Surgical Neuro-oncology (1998 - 2006)
Honors and Awards
- Excellence in Resident Teaching, Stanford Neurosurgery (2000)
- Outstanding Teacher Award, MGH Neurosurgery (1994)
- Golden Amygdala Teaching Award, UCSF Neurosurgery (1990)
- Rhodes Scholarship, Rhodes Trust (1975-1978)
Professional Education
| Fellowship: | University of Pittsburgh School of Medicine PA (1990) |
| Board Certification: | Neurological Surgery, American Board of Neurological Surgery (1989) |
| Internship: | UCSF Medical Center, CA USA (1981) |
| Medical Education: | Harvard Medical School MA (1980) |
| MBA: | Boston University, Business Administration (1990) |
| MD: | Harvard Medical School, Medicine (1980) |
Graduate & Fellowship Program Affiliations
Scientific Focus
Current Research Interests
Microsurgical treatment of tumors of the brain, spinal cord, pituitary gland and skull base;
Radiosurgery of tumors;
Molecular biology of brain tumors.
Clinical Trials
- Not Recruiting XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
- Not Recruiting An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
- Not Recruiting Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme
- Recruiting Phase I/II Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases
- Recruiting Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer
Publications
- Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery. 2013; (2): 180-5; discussion 185
- Diffusion-Weighted MRI: Distinction of Skull Base Chordoma from Chondrosarcoma. AJNR Am J Neuroradiol. 2013; (5): 1056-61
- Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage. J Biol Chem. 2013; (5): 3097-111
- Mucocele formation under pedicled nasoseptal flap. Am J Otolaryngol. 2012 Sep-Oct; (5): 634-6
- A Perspective on Craniopharyngioma. World Neurosurg. 2012
- Cochlea Radiation Dose Correlates with Hearing Loss After Stereotactic Radiosurgery of Vestibular Schwannoma. World Neurosurg. 2012
Help